Granules India (NSE:GRANULES) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Granules India FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Granules India's Free Cash Flow for the three months ended in Mar. 2024 was ₹0 Mil. Granules India's Revenue for the three months ended in Mar. 2024 was ₹11,758 Mil. Therefore, Granules India's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Granules India's current FCF Yield % is 0.57%.

The historical rank and industry rank for Granules India's FCF Margin % or its related term are showing as below:

NSE:GRANULES' s FCF Margin % Range Over the Past 10 Years
Min: -27.35 Med: -0.3 Max: 11.46
Current: 1.31

During the past 13 years, the highest FCF Margin % of Granules India was 11.46%. The lowest was -27.35%. And the median was -0.30%.

NSE:GRANULES's FCF Margin % is ranked better than
54.38% of 1028 companies
in the Drug Manufacturers industry
Industry Median: -0.05 vs NSE:GRANULES: 1.31

Granules India FCF Margin % Historical Data

The historical data trend for Granules India's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India FCF Margin % Chart

Granules India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

11.46

5.04

-1.76

7.27

1.31

Granules India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Granules India's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Granules India's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Granules India's FCF Margin % falls into.

Granules India FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Granules India's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	588.38	/	45063.67
	=	1.31 %

Granules India's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	11757.79
	=	0.00 %

Granules India FCF Margin % Related Terms

Thank you for viewing the detailed overview of Granules India's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Granules India (NSE:GRANULES) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (NSE:GRANULES) » Definitions » FCF Margin %

Traded in Other Exchanges

532482:India

Address

3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081

Website

https://www.granulesindia.com

Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (NSE:GRANULES) Headlines

No Headlines